Hno

Hno

SCHEMBL7400293

N=O.c1ccc2c(c1)COC2

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.42
MAOB P27338 3/20 0.42
CYP1A2 P05177 1/20 0.39
TSHR P16473 1/20 0.36
CYP2A6 P11509 2/20 0.36
CES1 P23141 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
MAPT P10636 2/20 0.33
HSD17B3 P37058 1/20 0.33
NOTUM Q6P988 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NISCH Q9Y2I1 1/20 0.32
IKBKB O14920 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29471383 0.91
SCHEMBL59871 0.91
Ammonia Solution, Strong SCHEMBL23320033 0.88 MAOA (0.40) MAOAMAOBCYP1A2TSHRCYP2A6
SCHEMBL16439994 0.88
Nitrous Acid SCHEMBL28700206 0.81 MAOA (0.38) MAOAMAOBCYP1A2TSHRCYP2A6
SCHEMBL2075437 0.79 MAOA (0.39) MAOAMAOBCYP1A2TSHRCES1
SCHEMBL11508366 0.77 LMNA (0.48) MAOAMAOBCYP1A2TSHRCA1
SCHEMBL11505205 0.77 LMNA (0.48) MAOAMAOBCYP1A2TSHRCA1
SCHEMBL11505396 0.77 LMNA (0.48) MAOAMAOBCYP1A2TSHRCA1
SCHEMBL11227471 0.77 LMNA (0.48) MAOAMAOBCYP1A2TSHRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
US-5877317-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 1999-03-02 US disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed